Stefan Knapp

48.5k total citations · 4 hit papers
516 papers, 29.0k citations indexed

About

Stefan Knapp is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Stefan Knapp has authored 516 papers receiving a total of 29.0k indexed citations (citations by other indexed papers that have themselves been cited), including 410 papers in Molecular Biology, 121 papers in Oncology and 64 papers in Organic Chemistry. Recurrent topics in Stefan Knapp's work include Protein Degradation and Inhibitors (129 papers), Ubiquitin and proteasome pathways (71 papers) and Protein Kinase Regulation and GTPase Signaling (50 papers). Stefan Knapp is often cited by papers focused on Protein Degradation and Inhibitors (129 papers), Ubiquitin and proteasome pathways (71 papers) and Protein Kinase Regulation and GTPase Signaling (50 papers). Stefan Knapp collaborates with scholars based in Germany, United Kingdom and United States. Stefan Knapp's co-authors include P. Filippakopoulos, Susanne Müller, O. Fedorov, A. Chaikuad, Alex N. Bullock, Rudolf Ladenstein, S. Picaud, J.E. Debreczeni, Paul E. Brennan and Jonathan M. Elkins and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Stefan Knapp

504 papers receiving 28.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family

2012 1.2k citations P. Filippakopoulos, S. Picaud et al. profile →
Targeting bromodomains: epigenetic readers of lysine acetylation

2014 957 citations P. Filippakopoulos, Stefan Knapp profile →
Trends in kinase drug discovery: targets, indications and inhibitor design

2021 510 citations Stefan Knapp et al. profile →
Copper is required for oncogenic BRAF signalling and tumorigenesis

2014 487 citations A. Chaikuad, Stefan Knapp et al. Nature profile →

Peers

Countries citing papers authored by Stefan Knapp

Since Specialization

Citations

This map shows the geographic impact of Stefan Knapp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Knapp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Knapp more than expected).

Fields of papers citing papers by Stefan Knapp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Knapp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Knapp. The network helps show where Stefan Knapp may publish in the future.

Co-authorship network of co-authors of Stefan Knapp

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Knapp. A scholar is included among the top collaborators of Stefan Knapp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Knapp. Stefan Knapp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of fully synthetic FKBP12-mTOR molecular glues 2025 ·Chemical Science ·(unknown), Christian Meyners, (unknown), (unknown), (unknown), Edvaldo Vasconcelos Soares Maciel, (unknown), Thomas Geiger, Stefan Knapp, Frederik Lermyte, Felix Hausch	12
2	Targeting bacterial kinases as a strategy to counteract antibiotic resistance 2025 ·Communications Chemistry ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Andreas Krämer, Stefan Knapp, Catherine Dunyach‐Remy, Katharina Rox, Jean‐François Guichou, Corinne Lionne, Felix Hausch	1
3	Discovery of an exquisitely selective WDR5 chemical probe accelerated by a high-quality DEL–ML Hit 2025 ·RSC Chemical Biology ·(unknown), (unknown), (unknown), Serah Kimani, (unknown), (unknown), Martin P. Schwalm, H. Holzmann, Andreas Krämer, A. Dong, Fengling Li, Irene Chau, (unknown), Matthias Gstaiger, Susanne Müller, Stefan Knapp, Václav Němec	1
4	Crystallographic fragment screening reveals ligand hotspots in TRIM21 PRY-SPRY domain 2025 ·Communications Chemistry ·(unknown), (unknown), (unknown), (unknown), Martin P. Schwalm, Krishna Saxena, Thomas Hanke, (unknown), (unknown), D. Fearon, F. von Delft, Andreas Krämer, Stefan Knapp	0
5	Development of Highly Potent and Selective Covalent FGFR4 Inhibitors Based on S _N Ar Electrophiles 2024 ·Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), Ramona Rudalska, (unknown), Martin P. Schwalm, (unknown), B.J. Wagner, Stefan Laufer, Stefan Knapp, Daniel Dauch, Matthias Gehringer	14
6	RUNX1 interacts with lncRNA SMANTIS to regulate monocytic cell functions 2024 ·Communications Biology ·(unknown), Timothy Warwick, (unknown), Stefan Günther, Sebastian Wolf, (unknown), (unknown), Katalin Pálfi, (unknown), (unknown), (unknown), Stefan Knapp, Andreas Weigert, Rajkumar Savai, Michael A. Rieger, Thomas Oellerich, Ilka Wittig, James A. Oo, Ralf P. Brandes, Matthias S. Leisegang	4
7	A machine learning and live-cell imaging tool kit uncovers small molecules induced phospholipidosis 2023 ·Cell chemical biology ·Huabin Hu, (unknown), Stefan Knapp, Albert A. Antolín, Susanne Müller	5
8	Toward effective Atg8‐based ATTECs: Approaches and perspectives 2023 ·Journal of Cellular Biochemistry ·Martin P. Schwalm, Stefan Knapp, Vladimir V. Rogov	3
9	Conformation and dynamics of the kinase domain drive subcellular location and activation of LRRK2 2021 ·Proceedings of the National Academy of Sciences ·Sven H. Schmidt, Jui‐Hung Weng, Phillip C. Aoto, Daniela Boassa, Sebastian Mathea, Steve Silletti, (unknown), Junru Hu, (unknown), Elizabeth A. Komives, Stefan Knapp, Friedrich W. Herberg, Susan S. Taylor	38
10	Mutation in Abl kinase with altered drug-binding kinetics indicates a novel mechanism of imatinib resistance 2021 ·Proceedings of the National Academy of Sciences ·Agatha Lyczek, Benedict‐Tilman Berger, (unknown), (unknown), (unknown), (unknown), (unknown), Steven K. Albanese, Matthew B. Robers, Stefan Knapp, John D. Chodera, Markus A. Seeliger	40
11	Structure of LRRK2 in Parkinson’s disease and model for microtubule interaction 2020 ·Nature ·(unknown), John Salogiannis, Sebastian Mathea, David Snead, Indrajit Lahiri, Mariusz Matyszewski, (unknown), Reika Watanabe, Jan Böhning, Andrew K. Shiau, Stefan Knapp, Elizabeth Villa, Samara L. Reck‐Peterson, Andrés E. Leschziner	143
12	Conservation of structure, function and inhibitor binding in UNC-51-like kinase 1 and 2 (ULK1/2) 2019 ·Biochemical Journal ·A. Chaikuad, Sebastian E. Koschade, Alexandra Stolz, (unknown), Christian Pohl, Shabnam Shaid, (unknown), Lester J. Lambert, Nicholas D. P. Cosford, Christian Brandts, Stefan Knapp	43
13	Hyperactive locomotion in a Drosophila model is a functional readout for the synaptic abnormalities underlying fragile X syndrome 2017 ·Science Signaling ·Risa Kashima, Patrick Redmond, (unknown), Sougata Roy, Thomas B. Kornberg, Thomas Hanke, Stefan Knapp, Giorgio Lagna, Akiko Hata	32
14	The MAPK Pathway Regulates Intrinsic Resistance to BET Inhibitors in Colorectal Cancer 2016 ·Clinical Cancer Research ·Yufang Ma, Lihong Wang, Leif R. Neitzel, Sudan N. Loganathan, Nan Tang, Lili Qin, (unknown), Yan Guo, Stefan Knapp, R. Daniel Beauchamp, Ethan Lee, Jialiang Wang	56
15	Cardiac myosin light chain is phosphorylated by Ca ²⁺ /calmodulin-dependent and -independent kinase activities 2016 ·Proceedings of the National Academy of Sciences ·Audrey N. Chang, P. Mahajan, Stefan Knapp, (unknown), H. Lee Sweeney, Kristine E. Kamm, James T. Stull	43
16	BRD4 localization to lineage-specific enhancers is associated with a distinct transcription factor repertoire 2016 ·Nucleic Acids Research ·Zeynab Najafova, Roberto Tirado-Magallanes, Malayannan Subramaniam, Tareq Hossan, (unknown), Sankari Nagarajan, Simon J. Baumgart, Vivek Kumar Mishra, Upasana Bedi, Eric Hesse, Stefan Knapp, John R. Hawse, Steven A. Johnsen	77
17	CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses 2015 ·Proceedings of the National Academy of Sciences ·Ariane Hammitzsch, C. Tallant, O. Fedorov, Alison O’Mahony, Paul E. Brennan, Duncan A. Hay, Fernando O. Martínez, Hussein Al‐Mossawi, Jelle de Wit, Matteo Vecellio, Christopher Wells, B P Wordsworth, Susanne Müller, Stefan Knapp, Paul Bowness	195
18	Inhibition of BET Bromodomain Targets Genetically Diverse Glioblastoma 2013 ·Clinical Cancer Research ·Zhixiang Cheng, Yuanying Gong, Yufang Ma, Kaihua Lu, Xiang Lu, Larry A. Pierce, Reid C. Thompson, Susanne Müller, Stefan Knapp, Jialiang Wang	233
19	Bromodomain-peptide displacement assays for interactome mapping and inhibitor discovery 2011 ·Molecular BioSystems ·Martin Philpott, Jing Yang, (unknown), O. Fedorov, Sagar Uttarkar, P. Filippakopoulos, S. Picaud, Tracy Keates, I. Felletar, Alessio Ciulli, Stefan Knapp, Tom D. Heightman	107
20	Structural Analysis Identifies Imidazo[1,2- b ]Pyridazines as PIM Kinase Inhibitors with In vitro Antileukemic Activity 2007 ·Cancer Research ·Vanda Pogačić, Alex N. Bullock, O. Fedorov, P. Filippakopoulos, Christelle Gasser, Andrea Biondi, Sandrine Meyer‐Monard, Stefan Knapp, Juerg Schwaller	169

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact